What Renaissance Technologies LLC changed, 2013 to 2026
53 quarterly 13F filings, from Q2 2013 to Q2 2026, each read from the filing itself. A quarter is compared only with the quarter before it, so a quarter with no filing is a gap in the record, not a sale.
Reported book
$72.6bn
$38.1bn at Q2 2013
Positions
3,140
2,756 at Q2 2013
Top ten weight
12%
11% at Q2 2013
Typical quarterly turnover
about 22%
Estimated from share changes
- Q2 2013: $38.1bn
- Q3 2013: $41.2bn
- Q4 2013: $41.8bn
- Q1 2014: $41.7bn
- Q2 2014: $42.9bn
- Q3 2014: $36.5bn
- Q4 2014: $41.4bn
- Q1 2015: $47.0bn
- Q2 2015: $43.9bn
- Q3 2015: $41.9bn
- Q4 2015: $45.9bn
- Q1 2016: $52.6bn
- Q2 2016: $52.5bn
- Q3 2016: $56.6bn
- Q4 2016: $63.2bn
- Q1 2017: $71.6bn
- Q2 2017: $78.4bn
- Q3 2017: $85.0bn
- Q4 2017: $90.7bn
- Q1 2018: $91.4bn
- Q2 2018: $91.7bn
- Q3 2018: $97.3bn
- Q4 2018: $91.3bn
- Q1 2019: $110bn
- Q2 2019: $114bn
- Q3 2019: $118bn
- Q4 2019: $130bn
- Q1 2020: $103bn
- Q2 2020: $116bn
- Q3 2020: $100bn
- Q4 2020: $92.1bn
- Q1 2021: $80.4bn
- Q2 2021: $80.1bn
- Q3 2021: $77.4bn
- Q4 2021: $80.4bn
- Q1 2022: $85.2bn
- Q2 2022: $84.5bn
- Q3 2022: $70.7bn
- Q4 2022: $73.1bn
- Q1 2023: $75.4bn
- Q2 2023: $69.4bn
- Q3 2023: $58.7bn
- Q4 2023: $64.6bn
- Q1 2024: $63.6bn
- Q2 2024: $59.0bn
- Q3 2024: $66.5bn
- Q4 2024: $67.6bn
- Q1 2025: $66.1bn
- Q2 2025: $75.2bn
- Q3 2025: $75.8bn
- Q4 2025: $64.5bn
- Q1 2026: $63.9bn
- Q2 2026: $72.6bn
- Q2 2013: 11%
- Q3 2013: 11%
- Q4 2013: 11%
- Q1 2014: 13%
- Q2 2014: 14%
- Q3 2014: 13%
- Q4 2014: 11%
- Q1 2015: 10%
- Q2 2015: 10%
- Q3 2015: 10%
- Q4 2015: 9%
- Q1 2016: 8%
- Q2 2016: 8%
- Q3 2016: 8%
- Q4 2016: 7%
- Q1 2017: 8%
- Q2 2017: 9%
- Q3 2017: 9%
- Q4 2017: 8%
- Q1 2018: 9%
- Q2 2018: 9%
- Q3 2018: 10%
- Q4 2018: 9%
- Q1 2019: 9%
- Q2 2019: 9%
- Q3 2019: 11%
- Q4 2019: 13%
- Q1 2020: 15%
- Q2 2020: 14%
- Q3 2020: 15%
- Q4 2020: 13%
- Q1 2021: 10%
- Q2 2021: 12%
- Q3 2021: 12%
- Q4 2021: 12%
- Q1 2022: 12%
- Q2 2022: 11%
- Q3 2022: 11%
- Q4 2022: 11%
- Q1 2023: 11%
- Q2 2023: 12%
- Q3 2023: 12%
- Q4 2023: 12%
- Q1 2024: 12%
- Q2 2024: 12%
- Q3 2024: 11%
- Q4 2024: 10%
- Q1 2025: 11%
- Q2 2025: 12%
- Q3 2025: 11%
- Q4 2025: 12%
- Q1 2026: 11%
- Q2 2026: 12%
The positions that defined it
Every position that was ever among the 25 largest: when it first appeared, when it was largest, and where it stands in Q2 2026. The line is its reported value each quarter.
| Position | Value over time | First listed | Largest | Q2 2026 |
|---|---|---|---|---|
| Nvidia Corp(NVDA) | Q2 2013 | $1.4bnQ2 2026 | $1.4bn | |
| Facebook Inc(META)Class A | Q3 2013 | $1.3bnQ2 2023 | $1.1bn | |
| Intel Corp(INTC) | Q2 2013 | $1.0bnQ2 2026 | $1.0bn | |
| United Therapeutics Corp Del(UTHR) | Q2 2013 | $1.1bnQ1 2026 | $926m | |
| Palantir Technologies Inc(PLTR)Class A | Q3 2021 | $1.8bnQ2 2025 | $883m | |
| Alphabet Inc(GOOGL)Capital Stock Class A | Q1 2016 | $828mQ2 2026 | $828m | |
| Exelixis Inc(EXEL) | Q2 2017 | $731mQ2 2026 | $731m | |
| Verisign Inc(VRSN) | Q2 2013 | $1.6bnQ2 2019 | $616m | |
| Kinross Gold Corp(KGC) | Q1 2019 | $780mQ1 2026 | $585m | |
| Crowdstrike HLDGS Inc(CRWD)Class A | Q2 2020 | $572mQ2 2026 | $572m | |
| Sterling Construction Co Inc(STRL) | Q1 2021 | $564mQ2 2026 | $564m | |
| Alphabet Inc(GOOG)Capital Stock Class C | Q1 2016 | $557mQ2 2026 | $557m | |
| Bristol Myers Squibb Co(BMY) | Q2 2013 | $3.9bnQ4 2019 | Soldlast listed Q1 2026 | |
| Abbvie Inc(ABBV) | Q2 2013 | $1.9bnQ2 2020 | Soldlast listed Q3 2025 | |
| Baidu Inc(BIDU)Sponsored ADR REP A | Q4 2013 | $1.9bnQ4 2020 | Soldlast listed Q4 2024 | |
| Celgene Corp | Q2 2013 | $1.5bnQ3 2019 | Soldlast listed Q3 2019 | |
| Biogen Idec Inc(BIIB) | Q2 2013 | $1.4bnQ1 2020 | Soldlast listed Q1 2026 | |
| Palo Alto Networks Inc(PANW) | Q1 2014 | $1.3bnQ4 2019 | Soldlast listed Q4 2025 | |
| Pinduoduo Inc(PDD)Sponsored ADS | Q2 2019 | $1.3bnQ4 2020 | Soldlast listed Q1 2026 | |
| Allergan PLC | Q4 2015 | $1.3bnQ1 2020 | Soldlast listed Q1 2020 |
Quarter by quarter
Q3 2020: $100bn across 3,333 positions
Against Q2 2020: 526 new, 1,146 added to, 1,655 trimmed, 573 sold out, across all 3,333 positions.
Turnover about 10% of the book, estimated from share changes at quarter-end prices.
Largest additions
- Procter & Gamble Co (PG)+$278m
- Nio Inc (NIO)+$224m
- Advanced Micro Devices Inc (AMD)+$189m
- Baidu Inc (BIDU)+$176m
- Home Depot Inc (HD)+$167m
- Maxim Integrated Prods Inc+$147m
- Automatic Data Processing In (ADP)+$135m
- Cisco Sys Inc (CSCO)+$128m
Largest reductions
- Tesla MTRS Inc (TSLA)-$1.2bn
- Bristol Myers Squibb Co (BMY)-$714m
- Abbvie Inc (ABBV)-$688m
- Wal-mart Stores Inc (WMT)-$603m
- T-mobile US Inc (TMUS)-$400m
- Newmont Mining Corp (NEM)-$285m
- Chipotle Mexican Grill Inc (CMG)-$282m
- Fortinet Inc (FTNT)-$273m
Opened
Nothing new among the largest positions.
Sold out
- Alibaba Group HLDG LTD (BABA)was $426m
- Spotify Technology S A (SPOT)was $326m
- Legg Mason Incwas $297m
- Nvidia Corp (NVDA)was $297m
- Firstenergy Corp (FE)was $247m
- Snap Inc (SNAP)was $209m
- Peloton Interactive Inc (PTON)was $209m
- JPMorgan Chase & Co (JPM)was $207m
Largest positions, Q3 2020
The largest 25 of 3,333 reported positions; the largest 500 carry 82.1% of the reported value.
| Position | Value | Weight | On the quarter |
|---|---|---|---|
| Zoom Video Communications In (ZM) | $2.5bn | 2.5% | Trimmed |
| Novo-nordisk A S (NVO) | $2.0bn | 1.9% | Trimmed |
| Bristol Myers Squibb Co (BMY) | $1.8bn | 1.8% | Trimmed |
| Vertex Pharmaceuticals Inc (VRTX) | $1.4bn | 1.4% | Trimmed |
| Chipotle Mexican Grill Inc (CMG) | $1.4bn | 1.4% | Trimmed |
| Verisign Inc (VRSN) | $1.3bn | 1.3% | Trimmed |
| Baidu Inc (BIDU) | $1.3bn | 1.3% | Added |
| Abbvie Inc (ABBV) | $1.2bn | 1.2% | Trimmed |
| Biogen Idec Inc (BIIB) | $1.1bn | 1.1% | Trimmed |
| Target Corp (TGT) | $1.1bn | 1.1% | Trimmed |
| Atlassian Corp PLC | $1.1bn | 1.1% | Trimmed |
| Monster Beverage Corp New (MNST) | $1.0bn | 1.0% | Trimmed |
| Kroger Co (KR) | $988m | 1.0% | Added |
| Palo Alto Networks Inc (PANW) | $962m | 1.0% | Trimmed |
| Pinduoduo Inc (PDD) | $866m | 0.9% | Added |
| Franco Nevada Corp (FNV) | $747m | 0.7% | Trimmed |
| Glaxosmithkline PLC | $690m | 0.7% | Trimmed |
| Horizon Therapeutics Pub LTD | $682m | 0.7% | Trimmed |
| eBay Inc (EBAY) | $670m | 0.7% | Trimmed |
| Humana Inc (HUM) | $661m | 0.7% | Trimmed |
| Abiomed Inc | $625m | 0.6% | Added |
| Molina Healthcare Inc (MOH) | $614m | 0.6% | Trimmed |
| Barrick Gold Corp | $603m | 0.6% | Trimmed |
| Regeneron Pharmaceuticals (REGN) | $600m | 0.6% | Added |
| Dominos Pizza Inc (DPZ) | $589m | 0.6% | Trimmed |
The books most like this one
Among the managers whose filings are on file, at Q2 2026. Overlap is the share of the two books that is the same: for every stock both list, the smaller of its two weights, added up. Two books can overlap because both own the largest companies; it says nothing about whether the managers agree.
| Manager | Overlap | Stocks in both | Overlap over time | |
|---|---|---|---|---|
| AQR Capital Management LLC | at least 26% | 191 | Compare | |
| Invesco Ltd | at least 25% | 175 | Compare | |
| Voloridge Investment Management LLC | at least 24% | 174 | Compare | |
| Arrowstreet Capital LP | at least 24% | 187 | Compare | |
| Acadian Asset Management LLC | at least 23% | 169 | Compare | |
| D. E. Shaw & Co. | at least 23% | 146 | Compare | |
| Man Group PLC | at least 23% | 163 | Compare | |
| Two Sigma Investments LP | at least 23% | 178 | Compare |
“At least” where either manager has more positions than are read each quarter: a stock both hold below that range is not counted.
The filings behind it
Every quarter above is one 13F holdings report, with any amendment the filer made to it applied in the order it was filed. Where the reporting entity changed, each quarter keeps the filer that actually reported it.
| Quarter | Filer | Book | Amended | Filing |
|---|---|---|---|---|
| Q2 2026 | Renaissance Technologies LLC | $72.6bn | 13F-HR | |
| Q1 2026 | Renaissance Technologies LLC | $63.9bn | 13F-HR | |
| Q4 2025 | Renaissance Technologies LLC | $64.5bn | 13F-HR | |
| Q3 2025 | Renaissance Technologies LLC | $75.8bn | 13F-HR | |
| Q2 2025 | Renaissance Technologies LLC | $75.2bn | 13F-HR | |
| Q1 2025 | Renaissance Technologies LLC | $66.1bn | 13F-HR | |
| Q4 2024 | Renaissance Technologies LLC | $67.6bn | 13F-HR | |
| Q3 2024 | Renaissance Technologies LLC | $66.5bn | 13F-HR | |
| Q2 2024 | Renaissance Technologies LLC | $59.0bn | 13F-HR | |
| Q1 2024 | Renaissance Technologies LLC | $63.6bn | 13F-HR | |
| Q4 2023 | Renaissance Technologies LLC | $64.6bn | 13F-HR | |
| Q3 2023 | Renaissance Technologies LLC | $58.7bn | 13F-HR | |
| Q2 2023 | Renaissance Technologies LLC | $69.4bn | 13F-HR | |
| Q1 2023 | Renaissance Technologies LLC | $75.4bn | 13F-HR | |
| Q4 2022 | Renaissance Technologies LLC | $73.1bn | 13F-HR | |
| Q3 2022 | Renaissance Technologies LLC | $70.7bn | 13F-HR | |
| Q2 2022 | Renaissance Technologies LLC | $84.5bn | 13F-HR | |
| Q1 2022 | Renaissance Technologies LLC | $85.2bn | 13F-HR | |
| Q4 2021 | Renaissance Technologies LLC | $80.4bn | 13F-HR | |
| Q3 2021 | Renaissance Technologies LLC | $77.4bn | 13F-HR | |
| Q2 2021 | Renaissance Technologies LLC | $80.1bn | 13F-HR | |
| Q1 2021 | Renaissance Technologies LLC | $80.4bn | 13F-HR | |
| Q4 2020 | Renaissance Technologies LLC | $92.1bn | 13F-HR | |
| Q3 2020 | Renaissance Technologies LLC | $100bn | 13F-HR | |
| Q2 2020 | Renaissance Technologies LLC | $116bn | 13F-HR | |
| Q1 2020 | Renaissance Technologies LLC | $103bn | 13F-HR | |
| Q4 2019 | Renaissance Technologies LLC | $130bn | 13F-HR | |
| Q3 2019 | Renaissance Technologies LLC | $118bn | 13F-HR | |
| Q2 2019 | Renaissance Technologies LLC | $114bn | 13F-HR | |
| Q1 2019 | Renaissance Technologies LLC | $110bn | 13F-HR | |
| Q4 2018 | Renaissance Technologies LLC | $91.3bn | 13F-HR | |
| Q3 2018 | Renaissance Technologies LLC | $97.3bn | 13F-HR | |
| Q2 2018 | Renaissance Technologies LLC | $91.7bn | 13F-HR | |
| Q1 2018 | Renaissance Technologies LLC | $91.4bn | 13F-HR | |
| Q4 2017 | Renaissance Technologies LLC | $90.7bn | 13F-HR | |
| Q3 2017 | Renaissance Technologies LLC | $85.0bn | 13F-HR | |
| Q2 2017 | Renaissance Technologies LLC | $78.4bn | 13F-HR | |
| Q1 2017 | Renaissance Technologies LLC | $71.6bn | 13F-HR | |
| Q4 2016 | Renaissance Technologies LLC | $63.2bn | 13F-HR | |
| Q3 2016 | Renaissance Technologies LLC | $56.6bn | 13F-HR | |
| Q2 2016 | Renaissance Technologies LLC | $52.5bn | 13F-HR | |
| Q1 2016 | Renaissance Technologies LLC | $52.6bn | 13F-HR | |
| Q4 2015 | Renaissance Technologies LLC | $45.9bn | 13F-HR | |
| Q3 2015 | Renaissance Technologies LLC | $41.9bn | 13F-HR | |
| Q2 2015 | Renaissance Technologies LLC | $43.9bn | 13F-HR | |
| Q1 2015 | Renaissance Technologies LLC | $47.0bn | 13F-HR | |
| Q4 2014 | Renaissance Technologies LLC | $41.4bn | 13F-HR | |
| Q3 2014 | Renaissance Technologies LLC | $36.5bn | 13F-HR | |
| Q2 2014 | Renaissance Technologies LLC | $42.9bn | 13F-HR | |
| Q1 2014 | Renaissance Technologies LLC | $41.7bn | 13F-HR | |
| Q4 2013 | Renaissance Technologies LLC | $41.8bn | 13F-HR | |
| Q3 2013 | Renaissance Technologies LLC | $41.2bn | 13F-HR | |
| Q2 2013 | Renaissance Technologies LLC | $38.1bn | 13F-HR |
Reading this record
A 13F lists US-listed long equity and options at the quarter end, filed up to 45 days later. It shows what was held, not when it was bought or at what price, and nothing short. Where a quarter lists only the largest positions, a name missing from it may still be held below that range; the counts of what was opened and sold always cover the whole filing.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More